Logo image of HBI

HANESBRANDS INC (HBI) Stock Fundamental Analysis

NYSE:HBI - New York Stock Exchange, Inc. - US4103451021 - Common Stock - Currency: USD

4.73  +0.08 (+1.72%)

After market: 4.7498 +0.02 (+0.42%)

Fundamental Rating

3

Taking everything into account, HBI scores 3 out of 10 in our fundamental rating. HBI was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of HBI have multiple concerns. HBI is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

HBI had positive earnings in the past year.
HBI had a positive operating cash flow in the past year.
HBI had negative earnings in 4 of the past 5 years.
HBI had a positive operating cash flow in 4 of the past 5 years.
HBI Yearly Net Income VS EBIT VS OCF VS FCFHBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

HBI has a Return On Assets of -7.61%. This is in the lower half of the industry: HBI underperforms 68.00% of its industry peers.
With a Return On Equity value of -669.26%, HBI is not doing good in the industry: 88.00% of the companies in the same industry are doing better.
With a decent Return On Invested Capital value of 12.87%, HBI is doing good in the industry, outperforming 76.00% of the companies in the same industry.
HBI had an Average Return On Invested Capital over the past 3 years of 9.25%. This is in line with the industry average of 11.17%.
The 3 year average ROIC (9.25%) for HBI is below the current ROIC(12.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -7.61%
ROE -669.26%
ROIC 12.87%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
HBI Yearly ROA, ROE, ROICHBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

HBI has a Operating Margin of 12.67%. This is amongst the best in the industry. HBI outperforms 82.00% of its industry peers.
In the last couple of years the Operating Margin of HBI has declined.
HBI has a Gross Margin of 41.77%. This is in the lower half of the industry: HBI underperforms 66.00% of its industry peers.
HBI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.67%
PM (TTM) N/A
GM 41.77%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
HBI Yearly Profit, Operating, Gross MarginsHBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HBI is creating some value.
Compared to 1 year ago, HBI has more shares outstanding
HBI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for HBI is higher compared to a year ago.
HBI Yearly Shares OutstandingHBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
HBI Yearly Total Debt VS Total AssetsHBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

HBI has an Altman-Z score of 1.83. This is not the best score and indicates that HBI is in the grey zone with still only limited risk for bankruptcy at the moment.
HBI has a worse Altman-Z score (1.83) than 76.00% of its industry peers.
The Debt to FCF ratio of HBI is 23.24, which is on the high side as it means it would take HBI, 23.24 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HBI (23.24) is worse than 64.00% of its industry peers.
A Debt/Equity ratio of 53.45 is on the high side and indicates that HBI has dependencies on debt financing.
HBI has a worse Debt to Equity ratio (53.45) than 92.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 53.45
Debt/FCF 23.24
Altman-Z 1.83
ROIC/WACC1.3
WACC9.91%
HBI Yearly LT Debt VS Equity VS FCFHBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.55 indicates that HBI should not have too much problems paying its short term obligations.
HBI has a Current ratio of 1.55. This is in the lower half of the industry: HBI underperforms 66.00% of its industry peers.
HBI has a Quick Ratio of 1.55. This is a bad value and indicates that HBI is not financially healthy enough and could expect problems in meeting its short term obligations.
HBI has a worse Quick ratio (0.67) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.67
HBI Yearly Current Assets VS Current LiabilitesHBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 440.00% over the past year.
Measured over the past years, HBI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.96% on average per year.
Looking at the last year, HBI shows a very negative growth in Revenue. The Revenue has decreased by -30.56% in the last year.
The Revenue for HBI have been decreasing by -11.40% on average. This is quite bad
EPS 1Y (TTM)440%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%450%
Revenue 1Y (TTM)-30.56%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-34.25%

3.2 Future

Based on estimates for the next years, HBI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.58% on average per year.
The Revenue is expected to grow by 0.87% on average over the next years.
EPS Next Y21.72%
EPS Next 2Y15.11%
EPS Next 3Y13.68%
EPS Next 5Y14.58%
Revenue Next Year-3.32%
Revenue Next 2Y-1.94%
Revenue Next 3Y-1.02%
Revenue Next 5Y0.87%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HBI Yearly Revenue VS EstimatesHBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
HBI Yearly EPS VS EstimatesHBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.76, which indicates a very decent valuation of HBI.
Compared to the rest of the industry, the Price/Earnings ratio of HBI indicates a rather cheap valuation: HBI is cheaper than 86.00% of the companies listed in the same industry.
HBI is valuated cheaply when we compare the Price/Earnings ratio to 27.69, which is the current average of the S&P500 Index.
HBI is valuated cheaply with a Price/Forward Earnings ratio of 7.93.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HBI indicates a rather cheap valuation: HBI is cheaper than 92.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of HBI to the average of the S&P500 Index (37.36), we can say HBI is valued rather cheaply.
Industry RankSector Rank
PE 8.76
Fwd PE 7.93
HBI Price Earnings VS Forward Price EarningsHBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

72.00% of the companies in the same industry are more expensive than HBI, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HBI indicates a somewhat cheap valuation: HBI is cheaper than 68.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.56
EV/EBITDA 7.39
HBI Per share dataHBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5

4.3 Compensation for Growth

HBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HBI's earnings are expected to grow with 13.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3Y13.68%

More info and screens

0

5. Dividend

5.1 Amount

HBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HANESBRANDS INC

NYSE:HBI (7/23/2025, 8:04:00 PM)

After market: 4.7498 +0.02 (+0.42%)

4.73

+0.08 (+1.72%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners93.02%
Inst Owner Change0.04%
Ins Owners1.12%
Ins Owner Change4.53%
Market Cap1.67B
Analysts50.77
Price Target5.51 (16.49%)
Short Float %10.87%
Short Ratio7.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)117.65%
Min EPS beat(2)17.38%
Max EPS beat(2)217.92%
EPS beat(4)4
Avg EPS beat(4)78.8%
Min EPS beat(4)17.38%
Max EPS beat(4)217.92%
EPS beat(8)6
Avg EPS beat(8)45.62%
EPS beat(12)8
Avg EPS beat(12)30.73%
EPS beat(16)11
Avg EPS beat(16)26.04%
Revenue beat(2)1
Avg Revenue beat(2)-3.69%
Min Revenue beat(2)-7.43%
Max Revenue beat(2)0.05%
Revenue beat(4)1
Avg Revenue beat(4)-10.83%
Min Revenue beat(4)-27.34%
Max Revenue beat(4)0.05%
Revenue beat(8)1
Avg Revenue beat(8)-7.24%
Revenue beat(12)2
Avg Revenue beat(12)-5.92%
Revenue beat(16)4
Avg Revenue beat(16)-3.95%
PT rev (1m)0%
PT rev (3m)-14.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.68%
EPS NY rev (1m)0%
EPS NY rev (3m)4.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE 8.76
Fwd PE 7.93
P/S 0.48
P/FCF 16.56
P/OCF 12.88
P/B 38.5
P/tB N/A
EV/EBITDA 7.39
EPS(TTM)0.54
EY11.42%
EPS(NY)0.6
Fwd EY12.61%
FCF(TTM)0.29
FCFY6.04%
OCF(TTM)0.37
OCFY7.77%
SpS9.87
BVpS0.12
TBVpS-4.2
PEG (NY)0.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.61%
ROE -669.26%
ROCE 16.29%
ROIC 12.87%
ROICexc 13.76%
ROICexgc 34.66%
OM 12.67%
PM (TTM) N/A
GM 41.77%
FCFM 2.89%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
ROICexc(3y)9.89%
ROICexc(5y)12.07%
ROICexgc(3y)24.54%
ROICexgc(5y)28.18%
ROCE(3y)11.7%
ROCE(5y)13.75%
ROICexcg growth 3Y-1.22%
ROICexcg growth 5Y5.88%
ROICexc growth 3Y-7.77%
ROICexc growth 5Y0.09%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
F-Score4
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 53.45
Debt/FCF 23.24
Debt/EBITDA 4.46
Cap/Depr 37.03%
Cap/Sales 0.83%
Interest Coverage 250
Cash Conversion 24.97%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.67
Altman-Z 1.83
F-Score4
WACC9.91%
ROIC/WACC1.3
Cap/Depr(3y)95.15%
Cap/Depr(5y)77.33%
Cap/Sales(3y)1.91%
Cap/Sales(5y)1.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)440%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%450%
EPS Next Y21.72%
EPS Next 2Y15.11%
EPS Next 3Y13.68%
EPS Next 5Y14.58%
Revenue 1Y (TTM)-30.56%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-34.25%
Revenue Next Year-3.32%
Revenue Next 2Y-1.94%
Revenue Next 3Y-1.02%
Revenue Next 5Y0.87%
EBIT growth 1Y11.81%
EBIT growth 3Y-23.76%
EBIT growth 5Y-14.59%
EBIT Next Year26.54%
EBIT Next 3Y9.56%
EBIT Next 5Y8.73%
FCF growth 1Y133.33%
FCF growth 3Y-25.8%
FCF growth 5Y-20.26%
OCF growth 1Y256.3%
OCF growth 3Y-24.88%
OCF growth 5Y-19.94%